Next Article in Journal
Cost-Effectiveness of Adjuvanted Influenza Vaccine Compared with Standard and High-Dose Influenza Vaccines for Persons Aged ≥50 Years in Spain
Next Article in Special Issue
The Application of mRNA Technology for Vaccine Production—Current State of Knowledge
Previous Article in Journal
The Use of Residual Blood Specimens in Seroprevalence Studies for Vaccine-Preventable Diseases: A Scoping Review
 
 
Article

Article Versions Notes

Vaccines 2025, 13(3), 322; https://doi.org/10.3390/vaccines13030322
Action Date Notes Link
article html file updated 24 June 2025 20:45 CEST Update https://www.mdpi.com/2076-393X/13/3/322/html
article html file updated 18 March 2025 18:46 CET Original file -
article supplementary file uploaded. 18 March 2025 18:44 CET - https://www.mdpi.com/2076-393X/13/3/322#supplementary
article pdf uploaded. 18 March 2025 18:44 CET Version of Record https://www.mdpi.com/2076-393X/13/3/322/pdf
article xml uploaded. 18 March 2025 18:44 CET Update https://www.mdpi.com/2076-393X/13/3/322/xml
article xml file uploaded 18 March 2025 18:44 CET Original file -
Back to TopTop